PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0.489. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: T32 AI007319
NCI NIH HHS
Grant: T32 CA009054
NIAID NIH HHS
Grant: T32 AI141346
NIGMS NIH HHS
Grant: R25 GM055246
NIAID NIH HHS
Grant: R01 AI137239
NCI NIH HHS
Grant: P30 CA062203
National Institutes of Health
Grant: 3P30CA062203-27S1
Clinical Trial Advancement and Development for Sarcomas
National Institutes of Health
Grant: 2T32AI141346-06A1
T32 for Training in Microbiology & Infectious Diseases
National Institutes of Health
Grant: 2T32CA009054-16
CARCINOGENESIS
National Institutes of Health
Grant: 5T32AI007319-35
Virus-host interactions: a multi-scale training program
National Institutes of Health
Grant: 5R01EB013723-05
Partnership for Primary Care Imaging
American Cancer Society
U.S. Department of Defense
National Institutes of Health
Melanoma Research Alliance
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals